Concert Pharmaceuticals
Mr. Jeffrey A. Munsie has served as our Chief Legal Officer since September 2019. Prior to joining Concert Mr. Munsie served as Senior Vice President, General Counsel and Head of Corporate Operations at Merrimack Pharmaceuticals, a biopharmaceutical company, from 2011 to 2019. Prior to Merrimack, he was a member of the corporate department at the law firm Wilmer Cutler Pickering Hale and Dorr in Boston from 2002 to 2011. Mr. Munsie received a J.D. from Harvard Law School and a B.A. from Dartmouth College.
This person is not in any offices
Concert Pharmaceuticals
Concert Pharmaceuticals is a clinical-stage biopharmaceutical company focused on applying its DCE Platform® (deuterated chemical entity platform) to create novel medicines designed to address unmet patient needs.